Peter DeMuth
Chief Tech/Sci/R&D Officer at ELICIO THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Peter DeMuth active positions
Companies | Position | Start | End |
---|---|---|---|
ELICIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-12-31 | - |
Career history of Peter DeMuth
Former positions of Peter DeMuth
Companies | Position | Start | End |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2017-07-31 | 2023-05-31 |
Training of Peter DeMuth
Massachusetts Institute of Technology | Doctorate Degree |
University of Maryland | Undergraduate Degree |
Statistics
International
United States | 5 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ELICIO THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Peter DeMuth
- Experience